tiprankstipranks
Intuitive Surgical (GB:0R29)
NASDAQ:0R29
UK Market
0R29
Intuitive Surgical
RESEARCH TOOLSreports

Intuitive Surgical (0R29) Share Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

0R29 Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
14 Buy
5 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Intuitive
Surgical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0R29 Stock 12 Month Forecast

Average Price Target

$614.00
▲(34.57% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $614.00 with a high forecast of $750.00 and a low forecast of $480.00. The average price target represents a 34.57% change from the last price of $456.27.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"438":"$438","751":"$751","516.25":"$516.3","594.5":"$594.5","672.75":"$672.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":750,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$750.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":614,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$614.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":480,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$480.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[438,516.25,594.5,672.75,751],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,487.9661538461538,509.8023076923077,531.6384615384616,553.4746153846154,575.3107692307692,597.146923076923,618.9830769230769,640.8192307692308,662.6553846153846,684.4915384615384,706.3276923076924,728.1638461538462,{"y":750,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,477.50461538461536,488.8792307692308,500.25384615384615,511.6284615384615,523.003076923077,534.3776923076923,545.7523076923077,557.126923076923,568.5015384615384,579.8761538461538,591.2507692307693,602.6253846153846,{"y":614,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,466.13,467.1969230769231,468.26384615384615,469.33076923076925,470.3976923076923,471.4646153846154,472.53153846153845,473.59846153846155,474.6653846153846,475.7323076923077,476.79923076923075,477.86615384615385,478.9330769230769,{"y":480,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":494.63,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":518.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":550.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":534.74,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":479.729,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":471.865,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":439.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":532.999,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":570.02,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.304,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.89,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.13,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$750.00Average Price Target$614.00Lowest Price Target$480.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on GB:0R29
Anthony Petrone
Mizuho Securities
Mizuho Securities
$475→$525
Hold
15.06%
Upside
Assigned
04/13/26
Intuitive Surgical price target lowered to $525 from $575 at MizuhoIntuitive Surgical price target lowered to $525 from $575 at Mizuho
BTIG Analyst forecast on GB:0R29
Ryan Zimmerman
BTIG
BTIG
$616→$574
Buy
25.80%
Upside
Assigned
04/13/26
Intuitive Surgical (ISRG) Gets a Buy from BTIG
Goldman Sachs Analyst forecast on GB:0R29
David Roman
Goldman Sachs
Goldman Sachs
$714→$609
Buy
33.47%
Upside
Assigned
04/09/26
Goldman Sachs Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Citi Analyst forecast on GB:0R29
Joanne Wuensch
Citi
Citi
$590
Buy
29.31%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Cigna (NYSE: CI) and Intuitive Surgical (NASDAQ: ISRG)
Evercore ISI Analyst forecast on GB:0R29
Vijay Kumar
Evercore ISI
Evercore ISI
$550→$480
Hold
5.20%
Upside
Reiterated
04/06/26
Intuitive Surgical price target lowered to $480 from $550 at Evercore ISIIntuitive Surgical price target lowered to $480 from $550 at Evercore ISI
William Blair Analyst forecast on GB:0R29
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
03/19/26
Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed
DBS Analyst forecast on GB:0R29
Nico Chen
DBS
DBS
$480
Hold
5.20%
Upside
Reiterated
03/18/26
Intuitive Surgical (ISRG) Gets a Hold from DBS
Bank of America Securities Analyst forecast on GB:0R29
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
03/18/26
Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)
UBS Analyst forecast on GB:0R29
Danielle Antalffy
UBS
UBS
$570→$550
Hold
20.54%
Upside
Assigned
03/17/26
Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS
RBC Capital Analyst forecast on GB:0R29
Shagun Singh Chadha
RBC Capital
RBC Capital
$650
Buy
42.46%
Upside
Reiterated
02/24/26
RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
TD Cowen Analyst forecast on GB:0R29
Mathew Blackman
TD Cowen
TD Cowen
$660
Buy
44.65%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)
Piper Sandler Analyst forecast on GB:0R29
Adam Maeder
Piper Sandler
Piper Sandler
$620
Buy
35.88%
Upside
Reiterated
02/02/26
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)
Morgan Stanley Analyst forecast on GB:0R29
Patrick Wood
Morgan Stanley
Morgan Stanley
$650
Buy
42.46%
Upside
Reiterated
01/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)
Oppenheimer Analyst forecast on GB:0R29
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
01/23/26
Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)
Truist Financial Analyst forecast on GB:0R29
Richard Newitter
Truist Financial
Truist Financial
$650
Buy
42.46%
Upside
Reiterated
01/23/26
Intuitive Surgical (ISRG) Gets a Buy from Truist Financial
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on GB:0R29
Anthony Petrone
Mizuho Securities
Mizuho Securities
$475→$525
Hold
15.06%
Upside
Assigned
04/13/26
Intuitive Surgical price target lowered to $525 from $575 at MizuhoIntuitive Surgical price target lowered to $525 from $575 at Mizuho
BTIG Analyst forecast on GB:0R29
Ryan Zimmerman
BTIG
BTIG
$616→$574
Buy
25.80%
Upside
Assigned
04/13/26
Intuitive Surgical (ISRG) Gets a Buy from BTIG
Goldman Sachs Analyst forecast on GB:0R29
David Roman
Goldman Sachs
Goldman Sachs
$714→$609
Buy
33.47%
Upside
Assigned
04/09/26
Goldman Sachs Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Citi Analyst forecast on GB:0R29
Joanne Wuensch
Citi
Citi
$590
Buy
29.31%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Cigna (NYSE: CI) and Intuitive Surgical (NASDAQ: ISRG)
Evercore ISI Analyst forecast on GB:0R29
Vijay Kumar
Evercore ISI
Evercore ISI
$550→$480
Hold
5.20%
Upside
Reiterated
04/06/26
Intuitive Surgical price target lowered to $480 from $550 at Evercore ISIIntuitive Surgical price target lowered to $480 from $550 at Evercore ISI
William Blair Analyst forecast on GB:0R29
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
03/19/26
Intuitive Surgical: Stapler Reload Recall Seen as Contained, Buy Rating Reaffirmed
DBS Analyst forecast on GB:0R29
Nico Chen
DBS
DBS
$480
Hold
5.20%
Upside
Reiterated
03/18/26
Intuitive Surgical (ISRG) Gets a Hold from DBS
Bank of America Securities Analyst forecast on GB:0R29
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
03/18/26
Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)
UBS Analyst forecast on GB:0R29
Danielle Antalffy
UBS
UBS
$570→$550
Hold
20.54%
Upside
Assigned
03/17/26
Intuitive Surgical price target lowered to $550 from $570 at UBSIntuitive Surgical price target lowered to $550 from $570 at UBS
RBC Capital Analyst forecast on GB:0R29
Shagun Singh Chadha
RBC Capital
RBC Capital
$650
Buy
42.46%
Upside
Reiterated
02/24/26
RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
TD Cowen Analyst forecast on GB:0R29
Mathew Blackman
TD Cowen
TD Cowen
$660
Buy
44.65%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Roche Holding (Other OTC: RHHBY) and Intuitive Surgical (NASDAQ: ISRG)
Piper Sandler Analyst forecast on GB:0R29
Adam Maeder
Piper Sandler
Piper Sandler
$620
Buy
35.88%
Upside
Reiterated
02/02/26
Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Intuitive Surgical (NASDAQ: ISRG) and Thermo Fisher (NYSE: TMO)
Morgan Stanley Analyst forecast on GB:0R29
Patrick Wood
Morgan Stanley
Morgan Stanley
$650
Buy
42.46%
Upside
Reiterated
01/28/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), HCA Healthcare (NYSE: HCA) and Intuitive Surgical (NASDAQ: ISRG)
Oppenheimer Analyst forecast on GB:0R29
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
01/23/26
Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)
Truist Financial Analyst forecast on GB:0R29
Richard Newitter
Truist Financial
Truist Financial
$650
Buy
42.46%
Upside
Reiterated
01/23/26
Intuitive Surgical (ISRG) Gets a Buy from Truist Financial
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months
xxx
Success Rate
22/29 ratings generated profit
76%
Average Return
+7.68%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 75.86% of your transactions generating a profit, with an average return of +7.68% per trade.
1 Year
Joanne WuenschCiti
Success Rate
19/24 ratings generated profit
79%
Average Return
+23.93%
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 79.17% of your transactions generating a profit, with an average return of +23.93% per trade.
2 Years
xxx
Success Rate
21/24 ratings generated profit
88%
Average Return
+44.69%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +44.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0R29 Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
30
29
32
29
12
Hold
7
8
8
9
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
37
40
38
17
In the current month, 0R29 has received 12 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 0R29 average Analyst price target in the past 3 months is 614.00.
Each month's total comprises the sum of three months' worth of ratings.

0R29 Financial Forecast

0R29 Earnings Forecast

Next quarter’s earnings estimate for 0R29 is $2.12 with a range of $2.03 to $2.35. The previous quarter’s EPS was $2.53. 0R29 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0R29 is $2.12 with a range of $2.03 to $2.35. The previous quarter’s EPS was $2.53. 0R29 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Sales Forecast

Next quarter’s sales forecast for 0R29 is $2.62B with a range of $2.56B to $2.71B. The previous quarter’s sales results were $2.87B. 0R29 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0R29 is $2.62B with a range of $2.56B to $2.71B. The previous quarter’s sales results were $2.87B. 0R29 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0R29 has Performed in-line its overall industry.

0R29 Stock Forecast FAQ

What is GB:0R29’s average 12-month price target, according to analysts?
Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 614.00.
    What is GB:0R29’s upside potential, based on the analysts’ average price target?
    Intuitive Surgical has 34.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Intuitive Surgical a Buy, Sell or Hold?
          Intuitive Surgical has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Intuitive Surgical’s share price target?
            The average share price target for Intuitive Surgical is 614.00. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $750.00 ,and the lowest forecast is $480.00. The average share price target represents 34.57% Increase from the current price of $456.27.
              What do analysts say about Intuitive Surgical?
              Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of Intuitive Surgical?
                To buy shares of GB:0R29, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.